How to Choose the Right Primary Antibody

Selecting the right primary antibody depends on your target protein, experimental application, and required specificity. Proteintech offers three types — polyclonal, monoclonal, and recombinant — each with distinct advantages depending on your research needs.

Polyclonal vs. Monoclonal vs. Recombinant

Polyclonal antibodies recognize multiple epitopes on a target protein, providing strong signal amplification. They are the best choice for detecting low-abundance proteins or targets in species with limited reagent availability. Because they bind multiple sites, polyclonals are more tolerant of minor protein modifications like point mutations or partial denaturation — making them reliable for Western blot and immunoprecipitation.

Monoclonal antibodies bind a single epitope with high specificity, producing clean results with low background. They are ideal for applications requiring precise discrimination between similar proteins, such as flow cytometry and immunohistochemistry. Monoclonals also provide consistent performance across lots, which matters for longitudinal studies.

Uni-rAb™ recombinant antibodies combine the specificity of monoclonals with guaranteed lot-to-lot consistency. Produced through Proteintech's ABCE™ cloning platform rather than traditional hybridomas, recombinant antibodies eliminate the risk of genetic drift that can cause performance changes between production batches. They are available in carrier-free PBS formulations for applications requiring conjugation or buffer flexibility.

Choosing by Application

Application Antibody Choices Benefits/When to choose
WB Polyclonal Antibodies Stronger signal for low-abundance targets
Monoclonal/Recombinant Antibodies Cleaner bands, identification of a single epitope (i.e. phosphorylation sites)
IHC Polyclonal Antibodies Stronger signal, identifies multiple epitopes which provides strong signal even if some epitopes are damaged or degraded
Monoclonal/Recombinant Antibodies Less background
IF Polyclonal Antibodies Brighter staining, better performance after fixation/permeabilization
Monoclonal/Recombinant Antibodies Pinpointing a single epitope on a protein, specific and accurate subcellular localization staining
FC Polyclonal Antibodies Higher sensitivity, better signal for low abundance targets, improved staining of epitopes masked by fixation/permeabilization protocols
Monoclonal/Recombinant Antibodies Consistent binding for population-level quantification
IP Polyclonal Antibodies Increased capture efficiency due to multiple epitope binding
Monoclonal/Recombinant Antibodies Pulldown of specific post-translational modifications, isotypes, isoforms, or members of a protein family
Multiplex Polyclonal Antibodies Low abundance targets or inaccessible epitope regions
Monoclonal/Recombinant Antibodies Consistent performance, less background, highest specificity

Antibodies verified with KD/KO Validation

Every Proteintech primary antibody is tested in-house using positive and negative controls. Over 4,000 targets include KD/KO validation — confirmed using knockout or knockdown cell lines to prove the antibody binds only its intended target. Validation data, application-specific images, and recommended dilutions are published on every product page.

With 400,000+ independent citations across peer-reviewed publications, Proteintech antibodies are among the most-referenced reagents in life science research. Citation counts are listed on each product page so you can evaluate real-world performance before purchasing.

Top Cited Antibodies